Current and projected patient and insurer costs for the care of patients with non-small cell lung cancer in the United States through 2040

Journal of Medical Economics
Lisa M HessAna B Oton

Abstract

The objective of this study was to quantify the current and to project future patient and insurer costs for the care of patients with non-small cell lung cancer in the US. An analysis of administrative claims data among patients diagnosed with non-small cell lung cancer from 2007-2015 was conducted. Future costs were projected through 2040 based on these data using autoregressive models. Analysis of claims data found the average total cost of care during first- and second-line therapy was $1,161.70 and $561.80 for patients, and $45,175.70 and $26,201.40 for insurers, respectively. By 2040, the average total patient out-of-pocket costs are projected to reach $3,047.67 for first-line and $2,211.33 for second-line therapy, and insurance will pay an average of $131,262.39 for first-line and $75,062.23 for second-line therapy. Claims data are not collected for research purposes; therefore, there may be errors in entry and coding. Additionally, claims data do not contain important clinical factors, such as stage of disease at diagnosis, tumor histology, or data on disease progression, which may have important implications on the cost of care. The trajectory of the cost of lung cancer care is growing. This study estimates that the cos...Continue Reading

References

Oct 1, 1992·Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition·M Roberts
Jun 1, 1992·Journal of Clinical Epidemiology·R A DeyoM A Ciol
May 26, 2004·Statistics in Medicine·Binbing YuEric J Feuer
Jul 2, 2010·Journal of Oncology Practice·Maurie Markman, Ryan Luce
Nov 26, 2010·Archives of Internal Medicine·Jeffrey T KullgrenTracy A Lieu
Jul 1, 2015·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Gayathri KumarKatherine B Winfree
Sep 28, 2015·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Jie TingLeslie Wilson
Jan 9, 2016·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Feb 3, 2016·Japanese Journal of Clinical Oncology·Hideyuki Akaza
Jan 4, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cathy J BradleyJoan L Warren

❮ Previous
Next ❯

Citations

Mar 29, 2019·Journal of Cellular and Molecular Medicine·Lei DaiHongxin Deng
Oct 18, 2020·Brain Sciences·Rita C CroomsBarbara G Vickrey
Dec 12, 2020·Expert Review of Pharmacoeconomics & Outcomes Research·Alain Vergnenegre, Christos Chouaid
Feb 28, 2021·PharmacoEconomics Open·Federico FelizziJoshua Ray
Apr 4, 2021·Current Oncology·Nicolas IragorriBeverley Essue
Feb 26, 2021·Future Oncology·Lisa M HessZhanglin Lin Cui

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Annals of Oncology : Official Journal of the European Society for Medical Oncology
R A Stahel
Lung Cancer : Journal of the International Association for the Study of Lung Cancer
Fabrice BarlésiJean-Louis Pujol
© 2022 Meta ULC. All rights reserved